Skip to content

Participate in our active studies Subscribe to our Mailing List

AB Science

Masitinib and AB8939 – Two compounds with breakthrough mechanism of action

Home
Company
Science
Pipeline
News and Media
Investors
Masivet®
- About Masivet®
- Medical information and Pharmacovigilance
Careers
Contact

Search:

Home
Company
Science
Pipeline
News and Media
Investors
Masivet®
- About Masivet®
- Medical information and Pharmacovigilance
Careers
Contact

Document de référence

You are here:

Home
Relations Investisseurs
Document de référence

Document de Référence

30/11/2016 – Document de Référence 2016

Post navigation

PreviousPrevious post:Documents relatifs aux Assemblées Générales NextNext post:Autres informations

Related Posts

Rapports financiers annuels
2 May 2018

Honoraires des Commissaires aux Comptes
2 May 2018

Déclaration mensuelle du nombre total d’actions en circulation et des droits de vote
2 May 2018

Documents relatifs aux Assemblées Générales
2 May 2018

Autres informations
2 May 2018

Calendrier Financier
2 May 2018

AB SCIENCE
HEADQUARTER

3, Avenue George V – 75008 PARIS – FRANCE
Tel. : +33 (0)1 47 20 00 14
Fax. : +33 (0)1 47 20 24 11

GENERAL INQUIRIES

contact@ab-science.com

PRODUCT INQUIRIES

masivet@ab-science.com

JOB INQUIRIES

careers@ab-science.com

CLINICAL INQUIRIES

clinical@ab-science.com

MEDIA / FINANCIAL INQUIRIES

investors@ab-science.com

PHARMACOVIGILANCE

pharmacovigilance@ab-science.com
Fax : +33 1 47 20 10 82

© AB Science – All right reserved